Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?

Alrun Schumann1, Elke Bucha, Götz Nowak

  • 1HaemoSys GmbH, Jena, Germany. goetz.nowak@med.uni-jena.de

Seminars in Thrombosis and Hemostasis
|September 9, 2005
PubMed
Summary

The platelet adhesion assay (PADA) offers a novel method to measure platelet adhesiveness. This assay can monitor antiplatelet drug effectiveness, including GPIIb/IIIa and ADP receptor antagonists like clopidogrel, and detect potential overdosing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined computational and experimental studies reveal an altered regiospecific switch in 5-lipoxygenase targeted by AKBA.

Biochemical and biophysical research communications·2026
Same author

Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).

Journal of thrombosis and haemostasis : JTH·2019
Same author

Disseminated intravascular coagulation does not play a major role in the pathogenesis of classical swine fever.

Veterinary microbiology·2012
Same author

A three-dimensional chemo-mechanical continuum model for smooth muscle contraction.

Journal of the mechanical behavior of biomedical materials·2012
Same author

Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling.

ChemMedChem·2012
Same author

Expression and characterization of recombinant ecarin.

The protein journal·2012

Area of Science:

  • Hematology
  • Pharmacology
  • Biotechnology

Background:

  • Platelet adhesion is a critical initial step in platelet activation, mediated by surface glycoproteins like GPIIb/IIIa and GPIb/V/IX.
  • Fibrinogen acts as a key adhesive protein, binding to GPIIb/IIIa receptors and facilitating platelet adhesion.

Purpose of the Study:

  • To introduce and validate the Platelet Adhesion Assay (PADA) as an innovative method for assessing platelet adhesiveness.
  • To demonstrate PADA's utility in monitoring GPIIb/IIIa receptor antagonists and detecting potential overdosing.
  • To evaluate PADA's capability in quantifying adenosine diphosphate (ADP) receptor antagonists, such as clopidogrel, and identifying patient responses.

Main Methods:

  • The PADA utilizes polymer particles coated with fibrinogen to measure platelet adhesion in ex vivo whole blood samples.

Related Experiment Videos

  • Experiments involved spiking blood with varying concentrations of GPIIb/IIIa inhibitors and measuring PADA.
  • Results were cross-validated with Flow Cytometry (FACS) for GPIIb/IIIa receptor occupancy.

    • Main Results:

    • PADA demonstrated consistency with FACS in assessing GPIIb/IIIa receptor occupancy.
    • The assay successfully quantified the effects of GPIIb/IIIa inhibitors and clopidogrel (an ADP receptor antagonist).
    • PADA identified patients with partial or complete clopidogrel resistance and detected drug overdoses.

    Conclusions:

    • PADA is a versatile and innovative assay for evaluating normal and abnormal platelet adhesiveness.
    • The assay effectively monitors the therapeutic effects of antiplatelet drugs targeting GPIIb/IIIa and ADP receptors.
    • PADA facilitates personalized antiplatelet therapy by enabling dose adjustments and identifying resistance or overdosing.